Alternating electric tumor treating fields for treatment of glioblastoma: rationale, preclinical, and clinical studies.
J Neurosurg
; 128(2): 414-421, 2018 02.
Article
en En
| MEDLINE
| ID: mdl-28298023
Palabras clave
GBM = glioblastoma; LYG = life years gained; MDR = multidrug resistant; NSCLC = nonsmall cell lung cancer; NovoTTF-100A; OS = overall survival; Optune; PFS = progression-free survival; QALY = quality-adjusted life year; QOL = quality of life; TMZ = temozolomide; TTF = tumor treating field; TTP = time to disease progression; alternating electric fields; newly diagnosed glioblastoma; oncology; recurrent glioblastoma; tumor treating fields
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Neoplasias Encefálicas
/
Terapia por Estimulación Eléctrica
/
Glioblastoma
Tipo de estudio:
Systematic_reviews
Idioma:
En
Revista:
J Neurosurg
Año:
2018
Tipo del documento:
Article